Alnylam Pharmaceuticals Inc Net Income per Employee (ALNY), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Alnylam Pharmaceuticals Inc   (NASDAQ: ALNY)
 

Alnylam Pharmaceuticals Inc Net Income per Employee

ALNY's Quarterly Results, Trends, Rankings, Statistics
Alnylam Pharmaceuticals Inc 's Income per employee grew in the second quarter 2026 on a trailing twelve month basis to , the contribution of Alnylam Pharmaceuticals Inc 's employees, reached a new high of $ 323,195income per employee.
The Healthcare sector has seen employees of 36 other companies achieving higher income per employee. While Alnylam Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 322 to 536.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALNY Net Income per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ 323,195 230,887 125,499 17,426 -127,636
ALNY's Total Ranking # 536 # 322 # 559 # 1614 # 2464
Seq. Net Income Change -20.15 % 10.5 % -25.75 % - -

ALNY Company Profile >> Back to ALNY Efficiency Comparisons >> Compare ALNY Net Income per Employee to its Competitors

ALNY Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 37
Healthcare Sector # 62
Overall Market # 536

Net Income per Employee Statistics
High Average Low
$ 323,195 $ -173,197 $ -472,849
(Jun 30 2026)   (Sep 30 2022)







Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026
Glucotrack Inc   554,600.00 $ 8.319  Million 15 
Eli Lilly And Company  534,224.00 $ 26,711.200  Million 50,000 
Silexion Therapeutics Corp  489,714.29 $ 6.856  Million 14 
Sanuwave Health Inc   488,872.73 $ 26.888  Million 55 
Acadia Pharmaceuticals Inc   476,796.99 $ 380.484  Million 798 
Biolife Solutions Inc   374,070.97 $ 57.981  Million 155 
Indivior Pharmaceuticals Inc   356,000.00 $ 356.000  Million 1,000 
Neurocrine Biosciences Inc   352,750.00 $ 705.500  Million 2,000 
Jazz Pharmaceuticals Plc  325,523.53 $ 940.763  Million 2,890 
Alnylam Pharmaceuticals Inc   323,195.20 $ 807.988  Million 2,500 
Spero Therapeutics Inc   295,320.00 $ 7.383  Million 25 
Eton Pharmaceuticals Inc   288,363.64 $ 12.688  Million 44 
Bristol myers Squibb Company  285,353.85 $ 9,274.000  Million 32,500 
Regeneron Pharmaceuticals Inc   280,902.01 $ 4,328.700  Million 15,410 
Adma Biologics Inc   261,139.10 $ 168.957  Million 647 
Siga Technologies Inc  247,213.16 $ 12.113  Million 49 
Interpace Biosciences Inc   239,676.47 $ 24.447  Million 102 
Lantheus Holdings Inc   230,766.97 $ 275.305  Million 1,193 
Entrada Therapeutics Inc   222,888.16 $ 33.879  Million 152 
Lensar Inc   219,520.00 $ 32.928  Million 150 
Standard Biotools Inc   218,267.35 $ 84.906  Million 389 
Meiragtx Holdings Plc  195,858.56 $ 78.931  Million 403 
Intuitive Surgical Inc   185,529.64 $ 3,157.900  Million 17,021 
Zoetis Inc   180,413.79 $ 2,616.000  Million 14,500 
Arcutis Biotherapeutics Inc   176,146.89 $ 62.356  Million 354 
Transmedics Group Inc   170,973.27 $ 153.534  Million 898 


Date modified: 2026-09-14T03:47:53+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.